Startup Insights

Castelion raised an $800M Series C with no public patent filings under its name. Read what the publication window means for a company founded in 2022.

AssistMe raised $7.5M with seven patent families, three granted, in a crowded claim space. Read what the filings and its hiring say about its position.

SweGaN raised a $14M Series B with seven patent families, four granted, and a last public filing from 2021. Read what the GaN-on-SiC portfolio shows.

Abcuro raised a $66M Series D. Read how its seven patent families, one granted, sit in a crowded biologics claim space and where the claims land.

Georgiamune raised a $92.7M Series B on 12 patent families across six patent offices, one granted. Read what the immunotherapy portfolio covers.

Leal Therapeutics raised a $30M Series A on seven patent families, all filed in 2024 and none granted yet. Read where its science is concentrated.

Gravis Robotics raised a $200M Series A on three patent families filed in 2024, none granted yet. Read what the publication lag means for its IP.

Groq raised a $350M Series A on 60 patent families, 37 granted, with NVIDIA as both investor and heaviest citer. Read what the portfolio covers.

Hubble Network raised $30M with eight US patent families, six granted, in CPC groups densely worked by Qualcomm. Read how its patents sit by the standard.